A comprehensive study on attention deficit hyperactivity disorder (ADHD) has revealed effective treatment options, providing clarity amidst years of mixed messages. Conducted by a team of researchers from the Université Paris Nanterre, Institut Robert-Debré du Cerveau de l’Enfant, and the University of Southampton, the analysis includes over 200 meta-analyses and aims to inform both patients and healthcare providers about evidence-based strategies for managing ADHD.
The findings, published in The BMJ on February 10, 2026, confirm that medication remains the most reliable treatment for both children and adults. In addition, cognitive behavioural therapy (CBT) is strongly supported as an effective option for adults. These conclusions are drawn from high-quality evidence derived from short-term clinical trials, highlighting the need for ongoing research into long-term treatment effects.
Interactive Platform Enhances Understanding of ADHD Treatments
To facilitate better decision-making, the researchers have launched an interactive public website, ebiadhd-database.org. This platform provides clear, evidence-based information about various interventions, which can often be overwhelming for individuals with ADHD and their families.
Professor Samuele Cortese, an NIHR Research Professor at the University of Southampton and the senior lead author of the study, stated, “We know that people with ADHD and their families are often overwhelmed by conflicting messages about which treatments work. We believe this study and the accompanying website provide the most authoritative, evidence-based, and accessible guidance currently available.”
The website aims to offer continuously updated, easy-to-understand information, making it a unique resource for patients and healthcare professionals alike.
Key Findings on ADHD Interventions
The study identified strong support for five medications used in children and adolescents, while two medications combined with CBT were effective for adults. Despite these promising findings, the evidence primarily pertains to short-term outcomes, raising concerns about the effectiveness of long-term treatment options.
Other interventions, such as acupuncture, mindfulness, and exercise, showed potential benefits. However, the studies backing these approaches generally lacked robustness, often involving small participant groups and a higher risk of bias. Notably, mindfulness emerged as the only intervention demonstrating significant benefits during extended follow-up periods, although the evidence base remains limited.
Dr. Corentin Gosling, Associate Professor at Université Paris Nanterre and the first lead author, emphasized the importance of accurate information for patients, stating, “Long waiting lists for mental health services are a major issue. Having incorrect information about treatments can make people’s journeys even more difficult, by wasting time and money on non-evidence-based approaches.”
The comprehensive review aligns with existing international clinical guidelines, confirming current recommendations while also evaluating treatments often overlooked in official guidelines. The researchers hope this initiative will influence clinical practice and policy, similar to their prior project focusing on autism treatments.
The study titled “Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making” is now available online, providing a significant resource for those affected by ADHD and the professionals who support them.
